Literature DB >> 31154142

Stepwise pH-sensitive and biodegradable polypeptide hybrid micelles for enhanced cellular internalization and efficient nuclear drug delivery.

Jing Qu1, Si Peng1, Rui Wang1, Sheng-Tao Yang1, Qing-Han Zhou2, Juan Lin3.   

Abstract

The short blood circulation time, reduced cellular uptake, and uncontrollable drug release still hinder the polymer micelle as an efficient drug delivery vehicle in clinical applications. In this study, a series of stepwise pH-sensitive and biodegradable polypeptide hybrid terpolymers, poly (lysine-co-N,N-bis(acryloyl) cystamine-co-dimethylmaleic anhydride) (PLB-DMMA), were designed and synthesized to achieve prolonged circulation time, enhanced cellular uptake and controllable anti-cancer drug release. The synthesized terpolymers can self-assemble into spherical nano-micelles (NMs) with narrow distributions and exhibited stepwise responses to extracellular and intracellular pH condition of the tumor cell. The as prepared NMs showed a negative surface charge under normal physiological conditions exhibiting advantageous stability during blood circulation. By the first-step pH response, the surface charge of the NMs switched from negative to positive to enhance cellular uptake under the slightly acidic tumor extracellular environment. After internalization into tumor cells, the second-step pH response resulted in an endosome escape of the NMs via the "proton-sponge" effect in the acidic endo/lysosome environment. Additionally, a rapid drug release was triggered in response to the intracellular reductive environment of tumor cells via the destruction of disulfide-linked polymer chains to enhance the nucleus delivery of DOX. in vitro cell assays showed that the blank NMs showed negligible systemic toxicity against normal cells while the DOX-loaded NMs significantly inhibited growth of the tumor cells. In general, it was suggested that the as developed stepwise pH-sensitive and biodegradable PLB-DMMA based NMs would be a smart and promising drug delivery candidate for anti-cancer chemotherapy.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Charge reversal; Drug delivery; Reduction-sensitive; Stepwise pH-sensitive

Mesh:

Substances:

Year:  2019        PMID: 31154142     DOI: 10.1016/j.colsurfb.2019.05.071

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

Review 1.  Syntheses of Polypeptides and Their Biomedical Application for Anti-Tumor Drug Delivery.

Authors:  Huayang Feng; Jonas Fabrizi; Jingguo Li; Christian Mayer
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

Review 2.  pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications.

Authors:  Rimesh Augustine; Nagendra Kalva; Ho An Kim; Yu Zhang; Il Kim
Journal:  Molecules       Date:  2019-08-15       Impact factor: 4.411

3.  Acid-Responsive Adamantane-Cored Amphiphilic Block Polymers as Platforms for Drug Delivery.

Authors:  Weiqiu Wen; Chong Guo; Jianwei Guo
Journal:  Nanomaterials (Basel)       Date:  2021-01-13       Impact factor: 5.076

Review 4.  Charge reversal nano-systems for tumor therapy.

Authors:  Peng Zhang; Daoyuan Chen; Lin Li; Kaoxiang Sun
Journal:  J Nanobiotechnology       Date:  2022-01-10       Impact factor: 10.435

Review 5.  Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.

Authors:  Hailong Tian; Tingting Zhang; Siyuan Qin; Zhao Huang; Li Zhou; Jiayan Shi; Edouard C Nice; Na Xie; Canhua Huang; Zhisen Shen
Journal:  J Hematol Oncol       Date:  2022-09-12       Impact factor: 23.168

Review 6.  Recent Advances in pH- or/and Photo-Responsive Nanovehicles.

Authors:  Yuseon Shin; Patihul Husni; Kioh Kang; Dayoon Lee; Sehwa Lee; Eunseong Lee; Yuseok Youn; Kyungtaek Oh
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

7.  Mesoscale Simulations of pH-Responsive Amphiphilic Polymeric Micelles for Oral Drug Delivery.

Authors:  Zhimin Wu; Manzhen Duan; Di Xiong; Can Yang Zhang
Journal:  Pharmaceutics       Date:  2019-11-20       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.